Johnson & Johnson is a Johnson & Johnson is the world’s largest and most diverse healthcare firm. Three divisions make up the firm: pharmaceutical, medical devices and diagnostics, and consumer.
Among the biggest risers on the S&P 500 on Friday January 22 was Johnson & Johnson ($JNJ), popping some 1.13% to a price of $163.55 a share with some 8.1 million shares trading hands.
Starting the day trading at $162.36, Johnson & Johnson reached an intraday high of $165.16 and hit intraday lows of $161.87. Shares gained $1.82 apiece by day’s end. Over the last 90 days, the stock’s average daily volume has been n/a of its 2.63 billion share total float. Today’s action puts the stock’s 50-day SMA at $n/a and 200-day SMA at $n/a with a 52-week range of $109.17 to $164.14.
Johnson & Johnson is the world’s largest and most diverse healthcare firm. Three divisions make up the firm: pharmaceutical, medical devices and diagnostics, and consumer. The drug and device groups represent close to 80% of sales and drive the majority of cash flows for the firm. The drug division focuses on the following therapeutic areas: immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases. The device segment focuses on orthopedics, surgery tools, vision care, and a few smaller areas. The last segment of consumer focuses on baby care, beauty, oral care, over-the-counter drugs, and women’s health. Geographically, just over half of total revenue is generated in the United States.
Johnson & Johnson has its corporate headquarters located in New Brunswick, NJ and employs 132,200 people. Its market cap has now risen to $430.55 billion after today’s trading, its P/E ratio is now n/a, its P/S n/a, P/B 6.68, and P/FCF n/a.